doi:

DOI: 10.3724/SP.J.1008.2011.00911

Academic Journal of Second Military Medical University (第二军医大学学报) 2011/31:8 PP.911-914

Absorbable hemostatic materials: safety and clinical application


Abstract:
This paper reviews the composition, mechanisms, safety and clinical application of major absorbable hemostatic materials, including oxidized cellulose, oxidized regenerated cellulose, thrombin sealants, fibrin glue, collagen, gelatin, α-cyanoacrylate sealants, bovine albumin and gluteraldehyde, chitosan-based hemostatic agents and microporous polysaccharide. Special attention was paid to the relationship between different absorbable hemostatic agents and the blood coagulation mechanism. We also discussed the future development of absorbable hemostatic agents.

Key words:absorbable hemostasis,hemostatic agents,topical hemostasis

ReleaseDate:2014-07-21 15:59:52

Funds:National Natural Science Foundation of China(30872629) and Shanghai Science and Technology Rising Star Program(10QH1403100)



[1] Jamborova G,Pospisilova N,Semecky V,Hyspler R,Ticha A,Pospechova K,et al.Microdispersed oxidized cellulose as a novel potential substance with hypolipidemic properties[J].Nutrition,2008,24:1174-1181.

[2] Krízova P,Masova L,Suttnar J,Salaj P,Dyr J E,Homola J,et al.The influence of intrinsic coagulation pathway on blood platelets activation by oxidized cellulose[J].Biomed Mater Res A,2007,82:274-280.

[3] Chapman W C,Singla N,Genyk Y,McNeil J W,Renkens K L Jr,Reynolds T C,et al.A phase 3,randomized,double-blind comparative study of the efficacyand safety of topical recombinant human thrombin andbovine thrombin in surgical hemostasis[J].Am Coll Surg,2007,205:256-265.

[4] Crean S,Michels S,Moschella K,Reynolds M.Bovine thrombin safety reporting:an example of study design and publication bias[J].Surg Res,2010,158:77-86.

[5] Tredree R B W,Debrix I,Eisert A.Evaluating the difference between fibrin sealants:recommendations from an international advisory panel of hospital pharmacists[J].EJHP Sci,2006,12:3-9.

[6] Fergusson D A,Hebert P C,Mazer C D,Fremes S,MacAdams C,Murkin J M,et al.A comparison of aprotinin and lysine analogues in high-risk cardiac surgery[J].N Engl J Med,2008,358:2319-2331.

[7] Gabay M.Absorbable hemostatic agents[J].Am J Health Syst Pharm,2006,63:1244-1253.

[8] Vargas M A.Dentin bonding:effects of hemostatic agents and caries detectors[J].Esthet Restor Dent,2009,21:75-76.

[9] Kim I Y,Eichel L,Edwards R,Uribe C,Chou D S,Abdelshehid C,et al.Effects of commonly used hemostatic agents on the porcine collecting system[J].J Endourol,2007,21:652-654.

[10] CoStasis Multi-center Collaborative Writing Committee.A novel collagen-based composite offers effective hemostasis for multiple surgical indications:Results of a randomized controlled trial[J].Surgery,2001,129:445-450.

[11] Igai H,Yamamoto Y,Chang S S,Yamamoto M,Tabata Y,Yokomise H.Tracheal cartilage regeneration by slow release of basic fibroblast growth factor from a gelatin sponge[J].J Thorac Cardiovasc Surg,2007,134:170-175.

[12] Martinowite U,Spotnite W D.Fibrin tissue adnesives[J].Thromb Haemost,1997,78:661.

[13] Ereth M H,Schaff M,Ericson E F,Wetjen N M,Nuttall G A,Oliver W C Jr.Comparative safety and efficacy of topical hemostatic agents in a rat neurosurgical model[J].Neurosurgery,2008,63:369-372.

[14] Eaglstein W H,Sullivan T.Cyanoacrylates for skin closure[J].Dermatol Clin,2005,23:193-198.

[15] Kinoshita Y,Matsuo M,Todoki K,Ozono S,Fukuoka S,Tsuzuki H,et al.Alveolar bone regeneration using absorbable poly(L-lactide-co-epsilon-caprolactone)/beta-tricalcium phosphate membrane and gelatin sponge incorporating basic fibroblast growth factor[J].Int J Oral Maxillofac Sur,2008,37:275-281.

[16] Karkouti K,Beattie W S.Aprotinin is useful as a hemostatic agent in cardiopulmonary surgery:no[J].J Thromb Haemost,2006,4:1879-1881.

[17] Lemaire S A,Ochoa L N,Conklin L D,Schmittling Z C,Undar A,Clubb F J,et al.Nerve and conduction tissue injury caused by contact with BioGlue[J].Surg Res,2007,143:286-293.

[18] LeMaire S A,Carter S A,Won T,Wang X,Conklin L D,Coselli J S.The threat of adhesive embolization:BioGlue leaks through needle holes in aortic tissue and prosthetic grafts[J].Ann Thorac Surg,2005,80:106-111.

[19] Millner R W,Lockhart A S,Bird H,Alexiou C.A new hemostatic agent:initial life-saving experience with Celox(chitosan) in cardiothoracic surgery[J].Ann Thorac Surg,2009,87:e13-e14.

[20] Kumar M N,Muzzarelli R A,Muzzarelli C,Sashiwa H,Domb AJ.Chitosan chemistry and pharmaceutical perspectives[J].Chem Rev,2004,104:6017-6084.

[21] 尹 刚,侯春林,刘万顺,韩宝芹,魏长征,刘双利,等.新型壳聚糖止血粉止血作用的实验研究[J].中国修复重建外科杂志,2009,23:1347-1349.

[22] Humphreys M R,Castle E P,Andrews P E,Gettman M T,Ereth M H.Microporous polysaccharide hemispheres for management of laparoscopic trocar injury to the spleen[J].Am J Surg,2008,195:99-103.

[23] Ferguson R E,Rinker B.The use of a hydrogel sealant on flexor tendon repairs to prevent adhesion formation[J].Ann Plast Surg,2006,56:54-58.

[24] 余雪松,黄赤兵,张银甫,冯嘉瑜.多孔止血淀粉在肾脏中止血效果的初步实验研究[J].重庆医学,2008,37:1520-1521,1524.

[25] 程 违.牛海绵状脑病通过医药产品传染的可能性[J].解放军预防医学杂志,1997,1:68.

[26] Weaver F A,Lew W,Granke K,Yonehiro L,Delange B,Alexander W A.A comparison of recombinant thrombin to bovine thrombin as a hemostatic ancillary in patients undergoing peripheral arterial bypass and arteriovenous graft procedures[J].Vasc Surg,2008,47:1266-1273.

PDF